Objective. To evaluate the reliability and validity of the Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD). Methods. The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-retest reliability analysis), normative data generation (303 normosmic subjects), validity analysis (comparison of Brief-IT-QOD scores of healthy and dysosmic subjects and scores correlation with psychophysical olfactory testing TDI and SNOT-22 scores), responsiveness analysis (10 dysosmic chronic rhinosinusitis with nasal polyps patients before and after biologic therapy), and cutoff value determination (ROC curve analysis of Brief-IT-QOD sensitivity and specificity). Results. All subjects completed the Brief-IT-QOD. Internal consistency (& alpha; > 0.70) and test-retest reliability (ICC > 0.7) were acceptable and satisfactory for both questionnaire subscales. A significant difference between dysosmic and control subjects was found in both subscales (p < 0.05). Significant correlations between subscales scores and TDI and SNOT-22 scores were observed. Brief-IT-QOD scores before treatment were significantly higher than after biological therapy. Conclusions. Brief-IT-QOD is reliable, valid, responsive to changes in QoL, and recommended for clinical practice and outcome research.

Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD)

Riva, Giuseppe;Albera, Andrea;Albera, Roberto;Motatto, Gian Marco;Pecorari, Giancarlo;
2023-01-01

Abstract

Objective. To evaluate the reliability and validity of the Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD). Methods. The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-retest reliability analysis), normative data generation (303 normosmic subjects), validity analysis (comparison of Brief-IT-QOD scores of healthy and dysosmic subjects and scores correlation with psychophysical olfactory testing TDI and SNOT-22 scores), responsiveness analysis (10 dysosmic chronic rhinosinusitis with nasal polyps patients before and after biologic therapy), and cutoff value determination (ROC curve analysis of Brief-IT-QOD sensitivity and specificity). Results. All subjects completed the Brief-IT-QOD. Internal consistency (& alpha; > 0.70) and test-retest reliability (ICC > 0.7) were acceptable and satisfactory for both questionnaire subscales. A significant difference between dysosmic and control subjects was found in both subscales (p < 0.05). Significant correlations between subscales scores and TDI and SNOT-22 scores were observed. Brief-IT-QOD scores before treatment were significantly higher than after biological therapy. Conclusions. Brief-IT-QOD is reliable, valid, responsive to changes in QoL, and recommended for clinical practice and outcome research.
2023
43
4
252
261
olfaction disorders; quality of life; questionnaire
Cardella, Arianna; Riva, Giuseppe; Preti, Andrea; Albera, Andrea; Luzi, Livio; Albera, Roberto; Cadei, Davide; Motatto, Gian Marco; Omenetti, Filippo; Pecorari, Giancarlo; Ottaviani, Francesco; Mozzanica, Francesco
File in questo prodotto:
File Dimensione Formato  
2023 - Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD).pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 211.87 kB
Formato Adobe PDF
211.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1933714
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact